Risk Reduction BehaviorOPTICARENCT01395095
OPTImal CArdiac REhabilitation (OPTICARE) Following Acute Coronary Syndromes
A study testing rehabilitation+telephonic coaching, OPTICARE-B and OPTICARE-C in people with Risk Reduction Behavior and Life Style, run by Erasmus Medical Center at 1 site in Netherlands.
Trial summary
The objective is to investigate whether in acute coronary syndrome patients the cardiac risk profile will improve with 2 new extended cardiac rehabilitation interventions and if these patients maintain healthier life style habits and a more active life style compared to patients randomized to standard cardiac… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Risk Reduction Behavior, Life Style
- What is being tested?
- rehabilitation+telephonic coaching, OPTICARE-B and OPTICARE-C
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 914 participants
- Where
- 1 siteNetherlands
- Study dates
- Sep 2011to Mar 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Patients with an acute coronary syndrome treated with primary or elective PCI or coronary surgery (CABG), with a stable medical condition and providing written informed consent are eligible to participate.
- Men and women who signed informed consent.
- Patients are eligible to participate in the study if they are: able to regularly attend a supervised exercise programme and able to complete Dutch language questionnaires.
Who cannot join
- Patients with heart failure
- Impaired left ventricular function (LVEF<40%)
- Psychic or cognitive impairments
- Severe arrhythmias
- Heart valve disease
- Congenital disease
- Severe co-morbidities which limit the CR (e.g. severe COPD, severe diabetes or locomotive disorder) and patients with an ICD will be excluded.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: OPTImal CArdiac REhabilitation (OPTICARE)Following Acute Coronary Syndromes: A Randomized, Controlled Trial to Investigate the Benefits of an Expanded Educational and Behavioural Intervention Program.
The objective is to investigate whether in acute coronary syndrome patients the cardiac risk profile will improve with 2 new extended cardiac rehabilitation interventions and if these patients maintain healthier life style habits and a more active life style compared to patients randomized to standard cardiac rehabilitation.
Read the detailed description
Rationale: Throughout the western world, healthy life style management is becoming increasingly important. Therefore, secondary prevention with an emphasis on lifestyle adjustments should be the cornerstone of modern cardiac rehabilitation (CR). This study may demonstrate the benefits of extended CR with respect to achieving optimal long term secondary prevention goals.
Objective: The objective is to investigate whether in acute coronary syndrome patients the cardiac risk profile will improve with 2 new extended cardiac rehabilitation interventions (OPTICARE and COACH) and if these patients maintain healthier life style habits and a more active life style compared to patients randomized to standard CR.
Study design: The proposed trial is a singlecenter, multi-disciplinary randomized controlled trial with a 18-month follow-up. In total 900 patients will be randomized into 3 arms:(1) Standard CR according to the Dutch guidelines; (2) OPTICARE intervention: standard CR and participation in multifactorial lifestyle sessions during rehabilitation and additional sessions at 4, 6 and 12 months and a personalized program to promote an active lifestyle; (3) COACH intervention: standard CR according to the Dutch guidelines followed by 5 telephone delivered coaching sessions starting at 6 weeks intervals (up to 6 months). The enrollment period will be 24 months, the intervention period is 12 months and the duration of the follow-up will be another 6 months. Assessments will take place at 4 time points: at baseline, 12 weeks after inclusion (end standard CR), at 12 and at 18 months.
Study population: Patients referred for standard CR will be included to participate in this trial. ACS patients treated with primary or elective PCI or CABG, with a stable medical condition and providing written informed consent are eligible to participate.
Intervention: OPTICARE intervention: Standard CR and obligation to participate in multifactorial lifestyle and risk factor sessions (medical information, dietary advises, risk factors and emotional advises). Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counsellor during and after completion of rehabilitation. If applicable, patients will participate in smoking cessation, dietary and stress management programs. Additional supervised multifactorial lifestyle and risk management training sessions of each 2 hours are provided at 4, 6 and 12 months. COACH intervention: standard CR according to the Dutch guidelines followed by 5 telephone based coaching sessions starting at 6 weeks intervals up to 6 months. The coaching sessions include assertiveness training, goal setting and reassessment.
Main study parameters/endpoints: The main objective is to investigate whether in patients randomized to extended CR (OPTICARE or COACH) cardiac risk profile will be improved, if these patients maintain healthier life style habits and do achieve an increase in daily activity level compared to patients randomized to standard CR.
Statistical Analysis Plan (SAP) of the OPTICARE study
Introduction The proposed trial is a single center, multi-disciplinary open-label randomized controlled trial. Between October 2011 and August 2014 922 patients were randomized into 3 arms:(1) Standard CR according to the Dutch guidelines (Opticare-Basic) (n=308); (2) OPTICARE intervention: standard CR with the addition of a personalized program to promote an active lifestyle. Besides, additional sessions were offered at 4, 6 and 12 months to improve long-term adherence to lifestyle changes. (Opticare-Capri) (n=310); (3) Heart COACH intervention: standard CR according to the Dutch guidelines followed by 5-6 telephone delivered coaching sessions starting one after finishing standard CR at 6 weeks intervals up to 12 months (Opticare-Achmea Heart Coach) (n=304). The intervention period is 12 months and the duration of the follow-up will be another 6 months. Assessments will take place at 4 time points: at baseline, 12 weeks after inclusion (end standard CR), at 12 and at 18 months.
Current status The study will be finished in January 2016. During September 2015 and January 2016 the data are checked and cleaned. In February 2016 the database will be closed and the statistical analyses can start.
Statistical analysis plan for Cardiology Primary end point and sample size Primary end point is the SCORE risk function measured at 18 months post randomization (Conroy RM et al, Eur HJ 2003; 24:987-1003). This score estimates 10-year risk of fatal cardiovascular disease. The SCORE risk function includes age, gender, systolic blood pressure, total cholesterol and smoking behaviour. The RESPONSE trial (Jorstadt HT, Heart 2013; 99:1421-1430) studied the effectiveness of a nurse-coordinated outpatient risk management program in cardiac patients. That strategy was associated with a 17 % reduction in SCORE Risk function as compared with standard care. Based on these data, and taking into account the more intensive interventions that we will perform, we expect in both the OPTICARE-CAPRI and in the OPTICARECOACH arm at least a 20 % reduction in the SCORE Risk Score at 1.5 years: from 5.40 to 4.32 points with an estimated standard deviation (SD) of 4.5. With 274 patients in each treatment arm, the study has 80 % power (beta-error=0.02) to detect this difference with an alpha-error of 0.05 (2-sided test). We will enroll a total 300 patients in each treatment arm, taking into account a 10 % drop-out rate.
N.B. In all analyses Opticare-Capri will be compared with Opticare-Basic and Opticare-Heart Coach with Opticare-Basic. The sample size computation was such that Opticare-Capri will not be compared with Opticare-Heart Coach.
Primary analysis: intention-to-treat In total, three analyses will be performed to investigate the consistency of the different analyses and to investigate whether differences between the methods can be explained.
Although according to the protocol, no comparisons will be made on cardiac events, these events (mortality, myocardial infarctions, coronary revascularizations and rehospitalizations for cardiac reasons) will be collected.
To be investigated: is the RISC score normally distributed? If necessary, a (ln-) transfrmation will be applied.
Analysis 1 (main analysis): SCORE risk function score at 18 months Opticare-Capri vs Opticare-Basic (student's t-test) and the same for Opticare-Capri vs Opticare-Basic.
Analyse 2:Mixed models will be used. These models takes into account missing data that is missing at random (Twisk, 2004). This analysis will include all patients with at least one measurement. All 4 time points will be included in these models (repeated measurements). At this way we can optimally analyze changes over time.
Analyse 3: Delta score 18 months vs baseline. All patients with a score at baseline and at 18 months will be included.
Secondary analyses: per protocol Patients have to attend at least 75% of the rehabilitation sessions to be included in the per protocol analysis, this means 18 training sessions. Besides, patients included in the Opticare-Achmea Heart Coach have to complete at least 3 out of 5 telephonic coaching sessions. Patients in the OPTICARE-Capri arm were invited to 3 active lifestyle intervention sessions and 3 multifactorial lifestyle and cardiovascular risk factor group intervention sessions. Only those Opticare patients who attended at least 4 of the 6 possible group sessions, will be included in this per-protocol analysis. It will be evaluated whether these results coincide with the intention-to-treat results.
The same analyses as described under the intention-to-treat analyses will be performed for the per protocol analysis and results will be compared to results of the intention-to-treat analyses.
In the intention-to-treat and in the per protocol analyses also the individual risks factors systolic blood pressure, total cholesterol and smoking behaviour will be analyzed separately as dependent variables.
Imputation No imputation will be performed on the end point parameters If necessary, multiple imputation on missing data of the baseline characteristics will be performed.
Statistical analysis plan for Rehabilitation Medicine Primary end point Primary end point is daily amount of moderate-to-vigorous physical activity (MVPA) measured by Actigraph (Bluetooth ® Smart wGT3X-BT).
Sample size Expected amount of minutes in (moderate-intensity) daily activity at 18 months post randomization Opticare-Basic program: 16 minutes/day (SD 13) Based on amount of minutes at start of rehabilitation(Ref. Oliveira and Stevenson et al) Opticare-Achmea Heart Coach: 25 minutes/day (SD 20) Based on amount of minutes at completion of standard CR (Ref. Stevenson et al), it is expected that patients in Opticare-Achmea Heart Coach reach (?) this level of activity Opticare-Capri: 32 minutes/day (SD 23) It is expected that patients in Opticare-Capri reach the recommended level of physical activity. At 2 year follow-up, Oliveira et al found that patients were active for a mean of 63.7 minutes at the end of a counselling session, long term effects are unknown. SD is based on highest SD measured by Oliveira.
With 202 patients in each treatment arm, the study has a power of 80% (beta-error=0.02) to detect this difference with an alpha-error of 0.05, taking into account the ANOVA Bonferroni correction (2-sided test) Taking into account missing values, failure of measurement system and drop outs (20%), a total of 245 patients in each treatment arm will be enrolled.
Analyses: per protocol Patients that dropped out of the study or CR program did not visit the center anymore, making it impossible to install the Actigraph device. Therefore, by design a mix of the intention-to-treat-analysis identical and a per-protocol analysis will be applied. In the CONSORT diagram this design will be explained in more detail.
Per-protocol analysis:
To be investigated: is MVPA normally distributed? If needed, a (ln-) transformation will be performed.
Analysis 1: MVPA at 18 months Opticare-Capri vs Opticare COACH vs Opticare-Basic (ANOVA) .
Analysis 2: Mixed models. These models takes into account missing data that is missing at random (Twisk, 2004).
This analysis will include all patients with at least one measurements. All 4 time points will be included in these models (repeated measurements). In this way we can optimally analyze changes over time.
Analysis 3: Delta minutes of MVPA 18 months vs baseline. All patients with a valid measurement at baseline and at 18 months will be included.
N.B. In the analyses also the minutes of sedentary behavior and the distribution of MVPA and sedentary behavior will be analyzed separately,
- Conditions
- Risk Reduction Behavior, Life Style
- Being tested
- rehabilitation+telephonic coaching, OPTICARE-B, OPTICARE-C
- Keywords
- cardiac rehabilitation, risk factor, lifestyle
- Medical subject headings
- Risk Reduction Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
rehabilitation+telephonic coachingOther
Also called cardiac rehabilitation
intervention starts 2 weeks after ending standard CR and is based on five phonebased coaching sessions at 6 weeks intervals up to 6 months. Each coaching session includes 5 stages: (1) Asking questions to establish patient's knowledge, attitude and beliefs about their risk factors; (2) Explanation and rationale; (3) Assertiveness training; (4) Goal setting; (5) Reassessment.
OPTICARE-BOther
Also called cardiac rehabilitation
standard CR according to the guidelines consisting of (a) 2 times a week exercise program of 1.5 hours during 12 weeks, (b) upon request of the patient: participation in multifactorial lifestyle and risk factor sessions (medical information, dietary advises and emotional advises, information about risk factors, smoking cessation program and stress management sessions).
OPTICARE-COther
Also called cardiac rehabilitation
(a) standard CR consisting of 2 times a week exercise program of 1.5 hours during 12 weeks. (b) (mandatory) participation in multifactorial lifestyle and risk factor sessions: i.e. 4 sessions of 2 hours each (medical information, dietary advises, risk factors and emotional advises). If applicable, patients will participate in smoking cessation, dietary and stress management programs . (c) Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counselor during and after completion of rehabilitation. Activity monitors will be used to provide feedback. (d) Additional compulsory supervised multifactorial lifestyle and risk management training sessions of each 2 hours provided at 4, 6 and 12 months.
| Study group | Role | What they receive |
|---|---|---|
| OPTICARE-A | Experimental | Starts 2 weeks after ending standard cardiac rehabilitation (CR) and is based on five phonebased coaching sessions at 6 weeks intervals up to 6 months. Each coaching session includes 5 stages: (1) Asking questions to establish patient's knowledge, attitude and beliefs about their risk factors; (2) Explanation and rationale; (3) Assertiveness training; (4) Goal setting; (5) Reassessment. Receives: Other: rehabilitation+telephonic coaching |
| OPTICARE-B | Active comparator | Standard CR according to the guidelines consisting of (a) 2 times a week exercise program of 1.5 hours during 12 weeks, (b) upon request of the patient: participation in multifactorial lifestyle and risk factor sessions (medical information, dietary advises and emotional advises, information about risk factors, smoking cessation program and stress management sessions) Receives: Other: OPTICARE-B |
| OPTICARE-C | Experimental | (a) standard CR consisting of 2 times a week exercise program of 1.5 hours during 12 weeks. (b) (mandatory) participation in multifactorial lifestyle and risk factor sessions: i.e. 4 sessions of 2 hours each (medical information, dietary advises, risk factors and emotional advises). If applicable, patients will participate in smoking cessation, dietary and stress management programs . (c) Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counselor during and after completion of rehabilitation. Activity monitors will be used to provide feedback. (d) Additional compulsory supervised multifactorial lifestyle and risk management training sessions of each 2 hours provided at 4, 6 and 12 months. Receives: Other: OPTICARE-C |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of the SCORE Risk Score
Healthy lifestyle is quantified by the SCORE Risk Score (7). Apart from age, sex, the SCORE includes the modifiable risk factors total cholesterol, HDL cholesterol, systolic blood pressure and smoking status.
Measured: 6 months after the intervention
Secondary outcomes (1)
improved physical fitness
increased level of everyday physical activity, reduction of health care consumption in the intervention groups and improved cost-effectiveness in the intervention groups.
Earlier return to work and improved social participation, improved physical fitness, improved quality of life and less anxiety and depression. On the long-term, patients will be followed up for adverse clinical outcome, defined as mortality and major adverse cardiac events,
Measured: 6 months after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jul 2011 (estimated)
- Study startSep 2011
- Primary completionMar 2016
- Study completionMar 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Risk Reduction BehaviorStudies of the same condition, open and under way.
- More trials run by Erasmus Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 914 participants (actual)
Sponsor and investigators
- Lead sponsor
- Erasmus Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ron T van Domburg, Erasmus Medical Center
- Investigators
- Ron T van Domburg, PhD, Principal investigator, ErasmusMC, ThoraxcenterFelix Zijlstra, MD, PhD, Study director, ErasmusMC, Thoraxcenter
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01395095
- Sponsor's protocol ID
- MEC-2010-391
- Acronym
- OPTICARE
- Status last verified
- Mar 2016
- First submitted
- 14 Jul 2011
- Last updated
- 15 Mar 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Yes
Publications
den Uijl I, Ter Hoeve N, Sunamura M, Lenzen MJ, Braakhuis HEM, Stam HJ, Boersma E, van den Berg-Emons RJG. Physical Activity and Sedentary Behavior in Cardiac Rehabilitation: Does Body Mass Index Matter? Phys Ther. 2021 Sep 1;101(9):pzab142. doi: 10.1093/ptj/pzab142.
PubMed 34089325de Bakker M, den Uijl I, Ter Hoeve N, van Domburg RT, Geleijnse ML, van den Berg-Emons RJ, Boersma E, Sunamura M. Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled Trial. Arch Phys Med Rehabil. 2020 Apr;101(4):650-657. doi: 10.1016/j.apmr.2019.11.017. Epub 2020 Jan 2.
PubMed 31904342Sunamura M, Ter Hoeve N, van den Berg-Emons RJG, Geleijnse ML, Haverkamp M, Stam HJ, Boersma E, van Domburg RT. Randomised controlled trial of two advanced and extended cardiac rehabilitation programmes. Heart. 2018 Mar;104(5):430-437. doi: 10.1136/heartjnl-2017-311681. Epub 2017 Sep 27.
PubMed 28954826
Study at a glance
From the registry record, last updated by the sponsor on 15 Mar 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- OPTImal CArdiac REhabilitation (OPTICARE)Following Acute Coronary Syndromes: A Randomized, Controlled Trial to Investigate the Benefits of an Expanded Educational and Behavioural Intervention Program.
- ClinicalTrials.gov ID
- NCT01395095
- Acronym / sponsor ID
- OPTICARE / MEC-2010-391
- Conditions
- Risk Reduction Behavior, Life Style
- Keywords
- cardiac rehabilitation, risk factor, lifestyle
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 914 participants (actual)
- Lead sponsor
- Erasmus Medical CenterUniversity, hospital or other
- Study start
- Sep 2011
- Primary completion
- Mar 2016 (actual)
- Study completion
- Mar 2016 (actual)
- First posted
- 15 Jul 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective is to investigate whether in acute coronary syndrome patients the cardiac risk profile will improve with 2 new extended cardiac rehabilitation interventions and if these patients maintain healthier life style habits and a more active life style compared to patients randomized to standard cardiac rehabilitation.
Detailed description
Rationale: Throughout the western world, healthy life style management is becoming increasingly important. Therefore, secondary prevention with an emphasis on lifestyle adjustments should be the cornerstone of modern cardiac rehabilitation (CR). This study may demonstrate the benefits of extended CR with respect to achieving optimal long term secondary prevention goals.
Objective: The objective is to investigate whether in acute coronary syndrome patients the cardiac risk profile will improve with 2 new extended cardiac rehabilitation interventions (OPTICARE and COACH) and if these patients maintain healthier life style habits and a more active life style compared to patients randomized to standard CR.
Study design: The proposed trial is a singlecenter, multi-disciplinary randomized controlled trial with a 18-month follow-up. In total 900 patients will be randomized into 3 arms:(1) Standard CR according to the Dutch guidelines; (2) OPTICARE intervention: standard CR and participation in multifactorial lifestyle sessions during rehabilitation and additional sessions at 4, 6 and 12 months and a personalized program to promote an active lifestyle; (3) COACH intervention: standard CR according to the Dutch guidelines followed by 5 telephone delivered coaching sessions starting at 6 weeks intervals (up to 6 months). The enrollment period will be 24 months, the intervention period is 12 months and the duration of the follow-up will be another 6 months. Assessments will take place at 4 time points: at baseline, 12 weeks after inclusion (end standard CR), at 12 and at 18 months.
Study population: Patients referred for standard CR will be included to participate in this trial. ACS patients treated with primary or elective PCI or CABG, with a stable medical condition and providing written informed consent are eligible to participate.
Intervention: OPTICARE intervention: Standard CR and obligation to participate in multifactorial lifestyle and risk factor sessions (medical information, dietary advises, risk factors and emotional advises). Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counsellor during and after completion of rehabilitation. If applicable, patients will participate in smoking cessation, dietary and stress management programs. Additional supervised multifactorial lifestyle and risk management training sessions of each 2 hours are provided at 4, 6 and 12 months. COACH intervention: standard CR according to the Dutch guidelines followed by 5 telephone based coaching sessions starting at 6 weeks intervals up to 6 months. The coaching sessions include assertiveness training, goal setting and reassessment.
Main study parameters/endpoints: The main objective is to investigate whether in patients randomized to extended CR (OPTICARE or COACH) cardiac risk profile will be improved, if these patients maintain healthier life style habits and do achieve an increase in daily activity level compared to patients randomized to standard CR.
Statistical Analysis Plan (SAP) of the OPTICARE study
Introduction The proposed trial is a single center, multi-disciplinary open-label randomized controlled trial. Between October 2011 and August 2014 922 patients were randomized into 3 arms:(1) Standard CR according to the Dutch guidelines (Opticare-Basic) (n=308); (2) OPTICARE intervention: standard CR with the addition of a personalized program to promote an active lifestyle. Besides, additional sessions were offered at 4, 6 and 12 months to improve long-term adherence to lifestyle changes. (Opticare-Capri) (n=310); (3) Heart COACH intervention: standard CR according to the Dutch guidelines followed by 5-6 telephone delivered coaching sessions starting one after finishing standard CR at 6 weeks intervals up to 12 months (Opticare-Achmea Heart Coach) (n=304). The intervention period is 12 months and the duration of the follow-up will be another 6 months. Assessments will take place at 4 time points: at baseline, 12 weeks after inclusion (end standard CR), at 12 and at 18 months.
Current status The study will be finished in January 2016. During September 2015 and January 2016 the data are checked and cleaned. In February 2016 the database will be closed and the statistical analyses can start.
Statistical analysis plan for Cardiology Primary end point and sample size Primary end point is the SCORE risk function measured at 18 months post randomization (Conroy RM et al, Eur HJ 2003; 24:987-1003). This score estimates 10-year risk of fatal cardiovascular disease. The SCORE risk function includes age, gender, systolic blood pressure, total cholesterol and smoking behaviour. The RESPONSE trial (Jorstadt HT, Heart 2013; 99:1421-1430) studied the effectiveness of a nurse-coordinated outpatient risk management program in cardiac patients. That strategy was associated with a 17 % reduction in SCORE Risk function as compared with standard care. Based on these data, and taking into account the more intensive interventions that we will perform, we expect in both the OPTICARE-CAPRI and in the OPTICARECOACH arm at least a 20 % reduction in the SCORE Risk Score at 1.5 years: from 5.40 to 4.32 points with an estimated standard deviation (SD) of 4.5. With 274 patients in each treatment arm, the study has 80 % power (beta-error=0.02) to detect this difference with an alpha-error of 0.05 (2-sided test). We will enroll a total 300 patients in each treatment arm, taking into account a 10 % drop-out rate.
N.B. In all analyses Opticare-Capri will be compared with Opticare-Basic and Opticare-Heart Coach with Opticare-Basic. The sample size computation was such that Opticare-Capri will not be compared with Opticare-Heart Coach.
Primary analysis: intention-to-treat In total, three analyses will be performed to investigate the consistency of the different analyses and to investigate whether differences between the methods can be explained.
Although according to the protocol, no comparisons will be made on cardiac events, these events (mortality, myocardial infarctions, coronary revascularizations and rehospitalizations for cardiac reasons) will be collected.
To be investigated: is the RISC score normally distributed? If necessary, a (ln-) transfrmation will be applied.
Analysis 1 (main analysis): SCORE risk function score at 18 months Opticare-Capri vs Opticare-Basic (student's t-test) and the same for Opticare-Capri vs Opticare-Basic.
Analyse 2:Mixed models will be used. These models takes into account missing data that is missing at random (Twisk, 2004). This analysis will include all patients with at least one measurement. All 4 time points will be included in these models (repeated measurements). At this way we can optimally analyze changes over time.
Analyse 3: Delta score 18 months vs baseline. All patients with a score at baseline and at 18 months will be included.
Secondary analyses: per protocol Patients have to attend at least 75% of the rehabilitation sessions to be included in the per protocol analysis, this means 18 training sessions. Besides, patients included in the Opticare-Achmea Heart Coach have to complete at least 3 out of 5 telephonic coaching sessions. Patients in the OPTICARE-Capri arm were invited to 3 active lifestyle intervention sessions and 3 multifactorial lifestyle and cardiovascular risk factor group intervention sessions. Only those Opticare patients who attended at least 4 of the 6 possible group sessions, will be included in this per-protocol analysis. It will be evaluated whether these results coincide with the intention-to-treat results.
The same analyses as described under the intention-to-treat analyses will be performed for the per protocol analysis and results will be compared to results of the intention-to-treat analyses.
In the intention-to-treat and in the per protocol analyses also the individual risks factors systolic blood pressure, total cholesterol and smoking behaviour will be analyzed separately as dependent variables.
Imputation No imputation will be performed on the end point parameters If necessary, multiple imputation on missing data of the baseline characteristics will be performed.
Statistical analysis plan for Rehabilitation Medicine Primary end point Primary end point is daily amount of moderate-to-vigorous physical activity (MVPA) measured by Actigraph (Bluetooth ® Smart wGT3X-BT).
Sample size Expected amount of minutes in (moderate-intensity) daily activity at 18 months post randomization Opticare-Basic program: 16 minutes/day (SD 13) Based on amount of minutes at start of rehabilitation(Ref. Oliveira and Stevenson et al) Opticare-Achmea Heart Coach: 25 minutes/day (SD 20) Based on amount of minutes at completion of standard CR (Ref. Stevenson et al), it is expected that patients in Opticare-Achmea Heart Coach reach (?) this level of activity Opticare-Capri: 32 minutes/day (SD 23) It is expected that patients in Opticare-Capri reach the recommended level of physical activity. At 2 year follow-up, Oliveira et al found that patients were active for a mean of 63.7 minutes at the end of a counselling session, long term effects are unknown. SD is based on highest SD measured by Oliveira.
With 202 patients in each treatment arm, the study has a power of 80% (beta-error=0.02) to detect this difference with an alpha-error of 0.05, taking into account the ANOVA Bonferroni correction (2-sided test) Taking into account missing values, failure of measurement system and drop outs (20%), a total of 245 patients in each treatment arm will be enrolled.
Analyses: per protocol Patients that dropped out of the study or CR program did not visit the center anymore, making it impossible to install the Actigraph device. Therefore, by design a mix of the intention-to-treat-analysis identical and a per-protocol analysis will be applied. In the CONSORT diagram this design will be explained in more detail.
Per-protocol analysis:
To be investigated: is MVPA normally distributed? If needed, a (ln-) transformation will be performed.
Analysis 1: MVPA at 18 months Opticare-Capri vs Opticare COACH vs Opticare-Basic (ANOVA) .
Analysis 2: Mixed models. These models takes into account missing data that is missing at random (Twisk, 2004).
This analysis will include all patients with at least one measurements. All 4 time points will be included in these models (repeated measurements). In this way we can optimally analyze changes over time.
Analysis 3: Delta minutes of MVPA 18 months vs baseline. All patients with a valid measurement at baseline and at 18 months will be included.
N.B. In the analyses also the minutes of sedentary behavior and the distribution of MVPA and sedentary behavior will be analyzed separately,
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| OPTICARE-A | Experimental | Other: rehabilitation+telephonic coachingStarts 2 weeks after ending standard cardiac rehabilitation (CR) and is based on five phonebased coaching sessions at 6 weeks intervals up to 6 months. Each coaching session includes 5 stages: (1) Asking questions to establish patient's knowledge, attitude and beliefs about their risk factors; (2) Explanation and rationale; (3) Assertiveness training; (4) Goal setting; (5) Reassessment. |
| OPTICARE-B | Active comparator | Other: OPTICARE-BStandard CR according to the guidelines consisting of (a) 2 times a week exercise program of 1.5 hours during 12 weeks, (b) upon request of the patient: participation in multifactorial lifestyle and risk factor sessions (medical information, dietary advises and emotional advises, information about risk factors, smoking cessation program and stress management sessions) |
| OPTICARE-C | Experimental | Other: OPTICARE-C(a) standard CR consisting of 2 times a week exercise program of 1.5 hours during 12 weeks. (b) (mandatory) participation in multifactorial lifestyle and risk factor sessions: i.e. 4 sessions of 2 hours each (medical information, dietary advises, risk factors and emotional advises). If applicable, patients will participate in smoking cessation, dietary and stress management programs . (c) Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counselor during and after completion of rehabilitation. Activity monitors will be used to provide feedback. (d) Additional compulsory supervised multifactorial lifestyle and risk management training sessions of each 2 hours provided at 4, 6 and 12 months. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Patients with an acute coronary syndrome treated with primary or elective PCI or coronary surgery (CABG), with a stable medical condition and providing written informed consent are eligible to participate.
- Men and women who signed informed consent.
- Patients are eligible to participate in the study if they are: able to regularly attend a supervised exercise programme and able to complete Dutch language questionnaires.
Key exclusion criteria (7 listed)
- Patients with heart failure
- Impaired left ventricular function (LVEF<40%)
- Psychic or cognitive impairments
- Severe arrhythmias
- Heart valve disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| rehabilitation+telephonic coachingAlso: cardiac rehabilitationintervention starts 2 weeks after ending standard CR and is based on five phonebased coaching sessions at 6 weeks intervals up to 6 months. Each coaching session includes 5 stages: (1) Asking questions to establish patient's knowledge, attitude and beliefs about their risk factors; (2) Explanation and rationale; (3) Assertiveness training; (4) Goal setting; (5) Reassessment. | Other | OPTICARE-A |
| OPTICARE-BAlso: cardiac rehabilitationstandard CR according to the guidelines consisting of (a) 2 times a week exercise program of 1.5 hours during 12 weeks, (b) upon request of the patient: participation in multifactorial lifestyle and risk factor sessions (medical information, dietary advises and emotional advises, information about risk factors, smoking cessation program and stress management sessions). | Other | OPTICARE-B |
| OPTICARE-CAlso: cardiac rehabilitation(a) standard CR consisting of 2 times a week exercise program of 1.5 hours during 12 weeks. (b) (mandatory) participation in multifactorial lifestyle and risk factor sessions: i.e. 4 sessions of 2 hours each (medical information, dietary advises, risk factors and emotional advises). If applicable, patients will participate in smoking cessation, dietary and stress management programs . (c) Individual sessions and a personalized home-based program to promote an active life style upon instruction of a physiotherapist and physical activity counselor during and after completion of rehabilitation. Activity monitors will be used to provide feedback. (d) Additional compulsory supervised multifactorial lifestyle and risk management training sessions of each 2 hours provided at 4, 6 and 12 months. | Other | OPTICARE-C |
Primary outcome
Reduction of the SCORE Risk Score
Time frame: 6 months after the intervention
Healthy lifestyle is quantified by the SCORE Risk Score (7). Apart from age, sex, the SCORE includes the modifiable risk factors total cholesterol, HDL cholesterol, systolic blood pressure and smoking status.
1 secondary outcome
improved physical fitness
Time frame: 6 months after the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Mar 2016.
- Derived from this study: PubMed 34089325den Uijl I, Ter Hoeve N, Sunamura M, Lenzen MJ, Braakhuis HEM, Stam HJ, Boersma E, van den Berg-Emons RJG. Physical Activity and Sedentary Behavior in Cardiac Rehabilitation: Does Body Mass Index Matter? Phys Ther. 2021 Sep 1;101(9):pzab142. doi: 10.1093/ptj/pzab142.
- Derived from this study: PubMed 31904342de Bakker M, den Uijl I, Ter Hoeve N, van Domburg RT, Geleijnse ML, van den Berg-Emons RJ, Boersma E, Sunamura M. Association Between Exercise Capacity and Health-Related Quality of Life During and After Cardiac Rehabilitation in Acute Coronary Syndrome Patients: A Substudy of the OPTICARE Randomized Controlled Trial. Arch Phys Med Rehabil. 2020 Apr;101(4):650-657. doi: 10.1016/j.apmr.2019.11.017. Epub 2020 Jan 2.
- Derived from this study: PubMed 28954826Sunamura M, Ter Hoeve N, van den Berg-Emons RJG, Geleijnse ML, Haverkamp M, Stam HJ, Boersma E, van Domburg RT. Randomised controlled trial of two advanced and extended cardiac rehabilitation programmes. Heart. 2018 Mar;104(5):430-437. doi: 10.1136/heartjnl-2017-311681. Epub 2017 Sep 27.
- Individual participant dataSharing planned: Yes
Related trials for Risk Reduction Behavior
Not yet recruiting
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
HIV Infections, HIV Prevention and Care
Recruiting
Communicating About Nicotine Reduction in Cigarettes
Tobacco Products, Smoking Behavior
Active, not recruiting
Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities
Healthy Subject
Recruiting
Applying CSNAT in HBPC as an Approach to Elder Mistreatment Risk Reduction
Caregiver Stress, Caregiver Health Related QOL
Recruiting
Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults
HIV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ron T van Domburg, PhD principal investigator
ErasmusMC, Thoraxcenter
Felix Zijlstra, MD, PhD study director
ErasmusMC, Thoraxcenter
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing rehabilitation+telephonic coaching, OPTICARE-B and OPTICARE-C in people with Risk Reduction Behavior and Life Style, run by Erasmus Medical Center at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of the SCORE Risk Score (time frame: 6 months after the intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01395095, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2016.